NASDAQ:CADL | Profit Breakdown | Candel Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-06-30 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$26.75M-$38.91M
2026-03-31-$16.28M-$8.86M
2025-12-31-$15.75M-$29.5M
2025-09-30-$13.21M-$11.27M
2025-06-30-$11.18M-$4.8M
2025-03-31-$8.13M$7.38M
2024-12-31-$8.14M-$14.07M
2024-09-30-$8.76M-$10.65M
2024-06-30-$8.57M-$22.24M
2024-03-31-$7.9M-$8.22M
2023-12-31-$10.32M-$11.1M
2023-09-30-$8.86M-$8.44M
2023-06-30-$9.58M-$9.61M
2023-03-31-$9.63M-$8.8M
2022-12-31$31,000.00-$8.1M-$5.08M
2022-09-30$31,000.00-$8.88M-$8.69M
2022-06-30$31,000.00-$8.75M-$4.15M
2022-03-31$31,000.00-$8.99M-$874,000.00
2021-12-31$31,000.00-$7.74M$1.6M
2021-09-30$31,000.00-$8.03M-$16.16M
2021-06-30$31,000.00-$5.3M-$17.08M
2021-03-31$31,000.00-$4.66M-$4.48M
2020-12-31$31,000.00-$6.13M-$10.48M
2020-09-30$31,000.00-$2.75M-$2.55M
2020-06-30$31,000.00-$2.62M-$2.88M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$48.27M-$38.18M-$38.18M
2024-12-31-$33.37M-$55.18M-$55.18M
2023-12-31-$38.39M-$37.94M
2022-12-31$125,000.00-$34.72M-$18.79M
2021-12-31$125,000.00-$25.73M-$36.12M
2020-12-31$125,000.00-$13.81M-$17.68M